Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
-
Field
-
will be part of the project group ''Cancer Biology in Silico '' led by Chloé B. Steen, with strong collaborations with researchers at Oslo University Hospital, University of Oslo, and Stanford University
-
contribute with own ideas and plans for clinical trials and epidemiology studies. via Unsplash Qualifications Applicants should hold an MD degree in medicine, and/or a PhD in biomedical data science or
-
at ARENA and WAGE. via Unsplash Qualification requirements Applicants must hold a degree equivalent to a Norwegian doctoral degree (PhD) in a relevant discipline within the social sciences before taking up
-
have one position available as a postdoctoral fellow at the University of Oslo, affiliated with the Centre for Precision Psychiatry at the Institute of Clinical Medicine. We invite applications for a 3
-
ambitious researcher with a relevant PhD to be part of the MAGIC project. The aim of the project is to uncover the role of metabolic dysfunction in psychosis, through the use of genomics, metabolomics and
-
for admission to the doctoral program. For more information, please see our website Doctoral degree: PhD in medicine and health sciences - Faculty of Medicine . Colourbox via Unsplash Colourbox Selection criteria
-
psychosis, through the use of genomics, metabolomics and neuroimaging data. A central part of the project is to develop and apply advanced biostatistical tools to predict clinical outcomes based on large
-
illness, and promote good health. The Institute is responsible for teaching in basic medical sciences for the programmes of professional study in medicine and the Master's programme in clinical nutrition
-
) , Department of Biostatistics, Institute of Basic Medical Sciences (IMB), University of Oslo (UiO), Norway. The candidate shall take part in the research group on “Statistical models for high-dimensional and
-
Medicine consists of 6 research groups, and a total of about 60 employees. The research profile of the Institute is to combine clinical medicine and molecular biology to establish a bridge between bench and